DK0813870T3 - Use of darifenacin to enhance cognitive functions - Google Patents

Use of darifenacin to enhance cognitive functions

Info

Publication number
DK0813870T3
DK0813870T3 DK97303879T DK97303879T DK0813870T3 DK 0813870 T3 DK0813870 T3 DK 0813870T3 DK 97303879 T DK97303879 T DK 97303879T DK 97303879 T DK97303879 T DK 97303879T DK 0813870 T3 DK0813870 T3 DK 0813870T3
Authority
DK
Denmark
Prior art keywords
darifenacin
cognitive functions
enhance cognitive
treatment
pharmaceutically acceptable
Prior art date
Application number
DK97303879T
Other languages
Danish (da)
Inventor
Michael John Allen
Brian Frank Johnson
Brian Robert Leaker
Robert Michael Wallis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0813870T3 publication Critical patent/DK0813870T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01007Acetylcholinesterase (3.1.1.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Eletrric Generators (AREA)
  • Soil Working Implements (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Chemical Treatment Of Metals (AREA)

Abstract

Darifenacin, and its pharmaceutically acceptable salts, are useful in the treatment of cognitive impairment. The invention also discloses the use of combinations of darifenacin, or a pharmaceutically acceptable salt thereof, with an acetylcholinesterase inhibitor, in the treatment of cognitive impairment.
DK97303879T 1996-06-18 1997-06-05 Use of darifenacin to enhance cognitive functions DK0813870T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612710.5A GB9612710D0 (en) 1996-06-18 1996-06-18 Method of treatment

Publications (1)

Publication Number Publication Date
DK0813870T3 true DK0813870T3 (en) 2003-08-18

Family

ID=10795468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97303879T DK0813870T3 (en) 1996-06-18 1997-06-05 Use of darifenacin to enhance cognitive functions

Country Status (15)

Country Link
US (1) US5837724A (en)
EP (1) EP0813870B1 (en)
JP (1) JP3453493B2 (en)
KR (1) KR980000445A (en)
AT (1) ATE243514T1 (en)
AU (1) AU2495697A (en)
CA (1) CA2208111C (en)
DE (1) DE69722999T2 (en)
DK (1) DK0813870T3 (en)
ES (1) ES2197972T3 (en)
GB (1) GB9612710D0 (en)
HU (1) HUP9701060A3 (en)
IL (1) IL121036A0 (en)
PT (1) PT813870E (en)
ZA (1) ZA975311B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19707655A1 (en) * 1997-02-26 1998-08-27 Hoechst Ag Combination preparation for use in dementia
US20040209849A1 (en) * 1998-11-27 2004-10-21 Sanochemia Pharmazeutika Aktiengesellschaft Use of effectors of the central cholinergic nervous system for treatment of delirium
GB0207104D0 (en) * 2002-03-26 2002-05-08 Pfizer Ltd Stable hydrate of a muscarinic receptor antagonist
US7317102B2 (en) * 2003-04-01 2008-01-08 Theravance, Inc. Diarylmethyl and related compounds
AU2009229372C1 (en) 2008-03-27 2017-02-02 Chase Pharmaceuticals Corporation Use and composition for treating dementia
EP3646870A1 (en) * 2009-07-22 2020-05-06 Puretech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
SG10202113198TA (en) * 2017-06-01 2021-12-30 Eisai R&D Man Co Ltd Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil
KR102408292B1 (en) 2018-09-28 2022-06-10 카루나 세러퓨틱스 인코포레이티드 Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness

Also Published As

Publication number Publication date
ZA975311B (en) 1998-12-17
ES2197972T3 (en) 2004-01-16
JP3453493B2 (en) 2003-10-06
DE69722999T2 (en) 2003-12-18
HUP9701060A3 (en) 1999-03-29
PT813870E (en) 2003-10-31
AU2495697A (en) 1998-01-08
US5837724A (en) 1998-11-17
DE69722999D1 (en) 2003-07-31
CA2208111A1 (en) 1997-12-18
IL121036A0 (en) 1997-11-20
ATE243514T1 (en) 2003-07-15
HU9701060D0 (en) 1997-08-28
EP0813870B1 (en) 2003-06-25
EP0813870A1 (en) 1997-12-29
JPH1059848A (en) 1998-03-03
HUP9701060A2 (en) 1998-12-28
GB9612710D0 (en) 1996-08-21
CA2208111C (en) 2002-10-15
KR980000445A (en) 1998-03-30

Similar Documents

Publication Publication Date Title
PT936908E (en) UTERIC ANTICONVULSIVE DERIVATIVES IN THE TREATMENT OF AMIOTROPHIC LATERAL SCLEROSIS (ELA)
DE69721254T8 (en) Face mask with universal adjustment
DE69513563D1 (en) Trocar with optics
DE69730043D1 (en) IMPLANTABLE ELETRODE LINE
LV12579B (en) The energy of the lawn and the change of energy
PT901487E (en) 4 (3H) -QUINAZOLINONES 2,3,6-TRISSUBSTITUIDES
DK0799819T3 (en) 1-Dimethylaminomethyl-2-phenylcycloalk-2-junctions having analgesic action
ID20531A (en) TREATMENT TOOL
DK0813870T3 (en) Use of darifenacin to enhance cognitive functions
DE29609021U1 (en) safety goggles
TR199501714A1 (en) Chilling object with holes.
DE59702263D1 (en) Purification of p.p-bisphenolate solutions
IT233164Y1 (en) BRANDINA OR CUCCIA PIEGHEGOLE AND / OR REMOVABLE.
FR2709944B1 (en) Surgical clip.
NL1000434C2 (en) Acetylene copolymers and membranes thereof.
ES1028150Y (en) PIECE OF BALLAST USED IN BELTS OF UNDERWATER ACTIVITIES.
ES1033996Y (en) GRAVES AND SIMILAR CRUSHER-SELECTOR MACHINE.
KR970050684U (en) Drowsiness Cap
KR900007413A (en) Prevention of AIDS, treatment and composition for the treatment
FI962173A0 (en) With the aid of the sawmill
KR970057938U (en) Drowsiness protector
DE29600133U1 (en) Cold or warming plasters
FR2708988B1 (en) Fake candle.
BR9602545A (en) Microkeratome
BR9600919A (en) Protector against burns on the stove